Identification and Management of Tardive Dyskinesia
Neurology and Neurosurgery
by ReachMD
1M ago
Guest: Amber Hoberg, PMHNP Guest: Jonathan M. Meyer, MD Tardive dyskinesia (TD) can be observed in patients receiving long-term treatment with dopamine receptor blocking agents. As the indications for these agents have expanded, TD is becoming more prevalent. In this activity, an expert reviews TD including risk factors, prevention, and treatment ..read more
Visit website
Patient Perspective: Living With Insomnia
Neurology and Neurosurgery
by ReachMD
2M ago
Host: Kevin Trice, MD Insomnia is characterized by difficulty falling asleep, staying asleep, and experiencing non-restorative or poor-quality sleep; it often leaves individuals feeling unrefreshed upon awakening. Symptoms during the day may include fatigue, irritability, impaired focus, and excessive sleepiness. The condition can significantly deteriorate a person’s quality of life, leading to reduced productivity, impaired cognitive function, mood disturbances, and an increased risk of accidents or injuries due to daytime sleepiness. This educational program delves into the pathophysiology ..read more
Visit website
Integrating Evidence and Cultural Sensitivity in Patient-Centric Insomnia Treatments
Neurology and Neurosurgery
by ReachMD
2M ago
Host: Kevin Trice, MD Host: Michael E. Yurcheshen, MD, FAASM Insomnia is characterized by difficulty falling asleep, staying asleep, and experiencing non-restorative or poor-quality sleep; it often leaves individuals feeling unrefreshed upon awakening. Symptoms during the day may include fatigue, irritability, impaired focus, and excessive sleepiness. The condition can significantly deteriorate a person’s quality of life, leading to reduced productivity, impaired cognitive function, mood disturbances, and an increased risk of accidents or injuries due to daytime sleepiness. This educational p ..read more
Visit website
Examining Treatment Options for Insomnia: From Orexin to GABA
Neurology and Neurosurgery
by ReachMD
2M ago
Host: Kevin Trice, MD Insomnia is characterized by difficulty falling asleep, staying asleep, and experiencing non-restorative or poor-quality sleep; it often leaves individuals feeling unrefreshed upon awakening. Symptoms during the day may include fatigue, irritability, impaired focus, and excessive sleepiness. The condition can significantly deteriorate a person’s quality of life, leading to reduced productivity, impaired cognitive function, mood disturbances, and an increased risk of accidents or injuries due to daytime sleepiness. This educational program delves into the pathophysiology ..read more
Visit website
Utilizing Assessment Tools in Insomnia
Neurology and Neurosurgery
by ReachMD
2M ago
Host: Michael E. Yurcheshen, MD, FAASM Insomnia is characterized by difficulty falling asleep, staying asleep, and experiencing non-restorative or poor-quality sleep; it often leaves individuals feeling unrefreshed upon awakening. Symptoms during the day may include fatigue, irritability, impaired focus, and excessive sleepiness. The condition can significantly deteriorate a person’s quality of life, leading to reduced productivity, impaired cognitive function, mood disturbances, and an increased risk of accidents or injuries due to daytime sleepiness. This educational program delves into the ..read more
Visit website
Exploring the Impact of Insomnia on Daytime Functioning and Cognition
Neurology and Neurosurgery
by ReachMD
2M ago
Host: Michael E. Yurcheshen, MD, FAASM Host: Kevin Trice, MD Insomnia is characterized by difficulty falling asleep, staying asleep, and experiencing non-restorative or poor-quality sleep; it often leaves individuals feeling unrefreshed upon awakening. Symptoms during the day may include fatigue, irritability, impaired focus, and excessive sleepiness. The condition can significantly deteriorate a person’s quality of life, leading to reduced productivity, impaired cognitive function, mood disturbances, and an increased risk of accidents or injuries due to daytime sleepiness. This educational p ..read more
Visit website
Sleep Architecture and Neurotransmitters of Sleep
Neurology and Neurosurgery
by ReachMD
2M ago
Host: Michael E. Yurcheshen, MD, FAASM Insomnia is characterized by difficulty falling asleep, staying asleep, and experiencing non-restorative or poor-quality sleep; it often leaves individuals feeling unrefreshed upon awakening. Symptoms during the day may include fatigue, irritability, impaired focus, and excessive sleepiness. The condition can significantly deteriorate a person’s quality of life, leading to reduced productivity, impaired cognitive function, mood disturbances, and an increased risk of accidents or injuries due to daytime sleepiness. This educational program delves into the ..read more
Visit website
Evidence-Based Discussion of the New and Emerging DMT Treatment Strategies for MCI
Neurology and Neurosurgery
by ReachMD
2M ago
Host: Sharon Cohen, MD, FRCPC Host: Richard S. Isaacson, MD Host: Marwan Noel Sabbagh, MD, FAAN, CCRI New data and emerging science have significantly advanced our understanding of the pathophysiology of mild cognitive impairment (MCI) and early-onset Alzheimer’s disease (AD). The FDA has recently approved new disease-modifying therapies (DMTs) that slow the clinical course of MCI caused by AD. This curriculum helps clinicians identify the subtle signs and symptoms of MCI in AD. The program also helps clinicians recognize why and how racial and ethnic differences and disparities affect DMT acc ..read more
Visit website
Disparities and Inequities in the Diagnosis and Care of Vulnerable Patient Populations
Neurology and Neurosurgery
by ReachMD
2M ago
Host: Marwan Noel Sabbagh, MD, FAAN, CCRI New data and emerging science have significantly advanced our understanding of the pathophysiology of mild cognitive impairment (MCI) and early-onset Alzheimer’s disease (AD). The FDA has recently approved new disease-modifying therapies (DMTs) that slow the clinical course of MCI caused by AD. This curriculum helps clinicians identify the subtle signs and symptoms of MCI in AD. The program also helps clinicians recognize why and how racial and ethnic differences and disparities affect DMT acceptance, patient outcomes, and disease onset and progression ..read more
Visit website
Evolving Treatment Paradigms For Mild Cognitive Impairment and Dementia: How New DMTs Will Fit Into Clinical Practice
Neurology and Neurosurgery
by ReachMD
2M ago
Host: Sharon Cohen, MD, FRCPC New data and emerging science have significantly advanced our understanding of the pathophysiology of mild cognitive impairment (MCI) and early-onset Alzheimer’s disease (AD). The FDA has recently approved new disease-modifying therapies (DMTs) that slow the clinical course of MCI caused by AD. This curriculum helps clinicians identify the subtle signs and symptoms of MCI in AD. The program also helps clinicians recognize why and how racial and ethnic differences and disparities affect DMT acceptance, patient outcomes, and disease onset and progression. Faculty di ..read more
Visit website

Follow Neurology and Neurosurgery on FeedSpot

Continue with Google
Continue with Apple
OR